184 related articles for article (PubMed ID: 33216971)
1. Pityriasis rosea-like eruption revealing COVID-19.
Veraldi S; Romagnuolo M; Benzecry V
Australas J Dermatol; 2021 May; 62(2):e333-e334. PubMed ID: 33216971
[No Abstract] [Full Text] [Related]
2. Pityriasis rosea as a leading manifestation of COVID-19 infection.
Merhy R; Sarkis AS; Stephan F
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e246-e247. PubMed ID: 33258224
[No Abstract] [Full Text] [Related]
3. Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
Martín Enguix D; Salazar Nievas MDC; Martín Romero DT
Med Clin (Barc); 2020 Sep; 155(6):273. PubMed ID: 32654832
[No Abstract] [Full Text] [Related]
4. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
Birlutiu V; Birlutiu RM; Iancu GM
Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113
[TBL] [Abstract][Full Text] [Related]
5. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Dursun R; Temiz SA
Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
[TBL] [Abstract][Full Text] [Related]
6. Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
Gökçek GE; Öksüm Solak E; Çölgeçen E
Dermatol Ther; 2022 Feb; 35(2):e15256. PubMed ID: 34881483
[No Abstract] [Full Text] [Related]
7. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.
Adya KA; Inamadar AC; Albadri W
Dermatol Ther; 2021 Sep; 34(5):e15040. PubMed ID: 34165237
[No Abstract] [Full Text] [Related]
8. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.
Ehsani AH; Nasimi M; Bigdelo Z
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e436-e437. PubMed ID: 32359180
[No Abstract] [Full Text] [Related]
9. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Valk B; Bender B
Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
[TBL] [Abstract][Full Text] [Related]
10. Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.
Carballido Vázquez AM; Morgado B
Br J Dermatol; 2021 Aug; 185(2):e34. PubMed ID: 33904157
[No Abstract] [Full Text] [Related]
11. Pityriasis rosea after mRNA COVID-19 vaccination.
Abdullah L; Hasbani D; Kurban M; Abbas O
Int J Dermatol; 2021 Sep; 60(9):1150-1151. PubMed ID: 34110010
[No Abstract] [Full Text] [Related]
12. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
Temiz SA; Abdelmaksoud A; Dursun R; Durmaz K; Sadoughifar R; Hasan A
J Cosmet Dermatol; 2021 Oct; 20(10):3080-3084. PubMed ID: 34363731
[No Abstract] [Full Text] [Related]
13. Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women.
Monastirli A; Pasmatzi E; Badavanis G; Tsambaos D
Acta Dermatovenerol Croat; 2016 Dec; 24(4):312-313. PubMed ID: 28128088
[TBL] [Abstract][Full Text] [Related]
14. Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19.
Dormann H; Grummt S; Karg M
Dtsch Arztebl Int; 2021 Jun; 118(25):431. PubMed ID: 34374333
[No Abstract] [Full Text] [Related]
15. Pityriasis rosea-like eruption induced by isotretinoin.
Gürel G; Şahin S; Çölgeçen E
Cutan Ocul Toxicol; 2018 Mar; 37(1):100-102. PubMed ID: 28359163
[TBL] [Abstract][Full Text] [Related]
16. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
Drago F; Broccolo F; Ciccarese G
Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
Welsh E; Cardenas-de la Garza JA; Cuellar-Barboza A; Franco-Marquez R; Arvizu-Rivera RI
Br J Dermatol; 2021 Jun; 184(6):1194-1195. PubMed ID: 33511657
[No Abstract] [Full Text] [Related]
18. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
Shin SH; Hong JK; Hong SA; Li K; Yoo KH
Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
[No Abstract] [Full Text] [Related]
19. Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions.
Welsh E; Cardenas-de la Garza JA; Brussolo-Marroquín E; Cuellar-Barboza A; Franco-Marquez R; Ramos-Montañez G
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e661-e662. PubMed ID: 35471706
[No Abstract] [Full Text] [Related]
20. Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.
Akdaş E; İlter N; Öğüt B; Erdem Ö
J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e491-e493. PubMed ID: 33914958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
